Mainstream

Alnylam to advance Roche-partnered heart drug to late-stage trial despite mid-stage setback

Alnylam to advance Roche-partnered heart drug to late-stage trial despite mid-stage setback

Post Contentalny, rhhbf, rhhbyRead More

You might also be interested in reading Telephone and Data Systems declares $0.04 dividend.

August 30, 2025
In Mainstream